Epilepsy is a group
of neurological diseases characterized by epileptic seizures. Epileptic
seizures are episodes that can vary from brief and nearly undetectable to long
periods of vigorous shaking. These episodes can result in physical injuries
including occasionally broken bones. The medical definition of this disease is
as a “condition characterized by recurrent (two or more) epileptic seizures,
unprovoked by any immediate identified cause”. Epilepsy is divided into four
main types; idiopathic generalized epilepsy, idiopathic partial epilepsy,
symptomatic generalized epilepsy and symptomatic partial epilepsy. The cause of
epilepsy can be genetic, a result of other disorders such as tumor or brain
injury and due to certain seizure triggers.
Purchase a copy of Global Epilepsy Market
visit @ http://www.orbisresearch.com/contact/purchase/208134
For more information contact sales@orbisresearch.com .
Epilepsy is treated
via antiepileptic drugs, surgery in certain cases and several complementary
therapies such as ketogenic diets or neural stimulation. Based upon the drug
type, epilepsy market can be divided into three main categories; first
generation drugs, second generation drugs and third generation drugs.
The global epilepsy
market is driven by factors such as development of novel drugs, launch of new
drugs in developing regions and prevalence of neural disorders such as meningitis
and tumors. This growth is then further spearheaded by increasing healthcare
expenses and rising disposable incomes. However, the market growth is hindered
by tedious drug approval process, generic erosion and high cost of treatment.
Trends such as companies focusing on developing effective therapies for
refractory epilepsy and physicians demanding higher efficacy drugs are listed
in this report.
Request a sample of Global Epilepsy Market
report @ http://www.orbisresearch.com/contacts/request-sample/208134 .
The report “Global
Epilepsy Drugs Market: Industry Analysis & Outlook (2017-2021)” analyzes
the development of this market, with focus on the Americas, EMEA and APAC regions.
The major trends, growth drivers as well as issues being faced by the market
are discussed in detail in this report. The four major players: Novartis AG.,
Pfizer Inc., GlaxoSmithKline Plc. and UCB are being profiled along with their
key financials and strategies for growth. The report contains a comprehensive
analysis of the global epilepsy drugs market along with the study of the
regional markets.
Browse Complete Global
Epilepsy Market @ http://www.orbisresearch.com/reports/index/global-epilepsy-market-industry-analysis-and-outlook-2017-2021/ .
Some points from TOC:
1. Overview
1.1 Epilepsy
1.2 Types of Epilepsy
1.3 Causes
1.5 Treatment
1.6 Epilepsy Market by Drug Class
1.1 Epilepsy
1.2 Types of Epilepsy
1.3 Causes
1.5 Treatment
1.6 Epilepsy Market by Drug Class
2. Global Antiepileptic Market
2.1 Global Antiepileptic Drugs Market Forecast by Value
2.2 Global Antiepileptic Drugs Market by Region
2.3 Global Antiepileptic Market by Drug Type
2.3.1 Global Branded Antiepileptic Drugs Market Forecast by Value
2.3.2 Global Generic Antiepileptic Drugs Market Forecast by Value
2.4 Global Branded Antiepileptic Market by Drug Class
2.4.1 Global Second Generation Antiepileptic Drugs Market Forecast by Value
2.4.2 Global Third Gen Branded Antiepileptic Market Forecast by Value
2.4.3 Global First Generation Antiepileptic Drugs Market Forecast by Value
2.1 Global Antiepileptic Drugs Market Forecast by Value
2.2 Global Antiepileptic Drugs Market by Region
2.3 Global Antiepileptic Market by Drug Type
2.3.1 Global Branded Antiepileptic Drugs Market Forecast by Value
2.3.2 Global Generic Antiepileptic Drugs Market Forecast by Value
2.4 Global Branded Antiepileptic Market by Drug Class
2.4.1 Global Second Generation Antiepileptic Drugs Market Forecast by Value
2.4.2 Global Third Gen Branded Antiepileptic Market Forecast by Value
2.4.3 Global First Generation Antiepileptic Drugs Market Forecast by Value
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment